VISUALMED CLINICAL SYSTEMS CORP
SB-2/A, EX-9, 2000-11-03
COMPUTER INTEGRATED SYSTEMS DESIGN
Previous: VISUALMED CLINICAL SYSTEMS CORP, SB-2/A, EX-5, 2000-11-03
Next: VISUALMED CLINICAL SYSTEMS CORP, SB-2/A, EX-10.1, 2000-11-03







Montreal, May 9, 2000



VisualMed Clinical Systems Inc.
391 Laurier Street West
Montreal, Quebec
H2V 2K3



Dear Sirs:

The following  will confirm that the  undersigned  is the  registered  holder of
10,000,000 voting but unregistered  common shares of VisualMed  Clinical Systems
Corp.  ("VisualMed U.S."), a Nevada corporation which is the registered owner of
all of the voting common shares of VisualMed  Clinical Systems Inc.  ("VisualMed
Canada") a Canadian corporation.  I acquired these shares (the "Special Shares")
for a  nominal  consideration  on May 9, 2000 to  assist  in  ensuring  that the
corporate  direction and management of VisualMed U.S. be exercised,  through me,
as described below.

The former  common  shareholders  of VisualMed  Canada have been issued in their
place  certain  exchangeable  shares  of  VisualMed  Canada  (the  "Exchangeable
Shares")  entitling  the holders,  following  exchange,  to receive in excess of
19,002,785  common shares of VisualMed  U.S., the whole pursuant to the Exchange
Agreement  entered into on May 1, 2000 by VisualMed U.S.,  VisualMed  Canada and
all holders of Exchangeable Shares (the "Exchange Agreement").

Accordingly, I undertake towards the holders of Exchangeable Shares of VisualMed
Canada,  firstly  that I shall take all steps as may be permitted or required of
me to cause the  election  and  maintain as the Board of  Directors of VisualMed
U.S. the following individuals, (as may be added or amended from time to time at
the  written  request or written  consent  of the  holders of a majority  of the
Exchangeable  Shares of  VisualMed  Canada,  which  request or consent  shall be
directed to the undersigned at the address of VisualMed Canada):

                  Gerard Dab
                  Arthur Gelston
                  Linda McHarg
                  Linda Snell
                  Richard Le Hir
                  Richard Borenstein
                  Caroline Singleton



Secondly,  I confirm to VisualMed  Canada and  undertake  towards the holders of
Exchangeable  Shares that I shall exercise any other rights of vote or otherwise
in my  capacity  as a  shareholder  of  VisualMed  U.S.  as may be  directed  or
consented to from time to time in writing to by the holders of a majority of the
Exchangeable  Shares of VisualMed  Canada,  then  outstanding,  which request or
consent shall be directed to the undersigned at the address of VisualMed Canada.

I will  continue  to be bound by this  undertaking  until  (i) the  Registration
statement on Form SB-2 with the United States Securities and Exchange Commission
has been rendered effective, which will register the 19,002,785 common shares of
VisualMed  U.S. in favour of the  holders of  Exchangeable  Shares of  VisualMed
Canada and (ii) such number of common shares of VisualMed  U.S. has been validly
issued  (from  the said  19,002,785  reserved  common  shares)  in favour of the
holders of  Exchangeable  Shares  that  represent  a majority  of all issued and
outstanding voting shares of VisualMed U.S. (the "Holding Period").

Upon the expiry of the Holding Period,  I have agreed to sell and VisualMed U.S.
has agreed to purchase,  for  cancellation,  further to a written  request to be
sent by me to VisualMed  U.S. (the  "Request"),  all of the Special Shares for a
nominal  consideration,  the whole  pursuant to an Agreement to Purchase  Common
Stock made between  VisualMed U.S. and the undersigned dated May 9, 2000, a copy
of which is attached.  I hereby agree that I shall send the Request,  asking for
the purchase and  cancellation of the Special Shares,  forthwith upon the expiry
of the Holding Period.  Upon purchase and  cancellation of the Special Shares by
VisualMed U.S., I shall have no further obligations under this agreement.

I further  agree and  undertake  for myself and my heirs,  successors  and legal
representatives that in the event of my death or incapacity, as the latter shall
be determined by two medical experts or by a definitive  judgment  rendered by a
court of  competent  jurisdiction,  there shall be a deemed  disposition  of the
Special Shares (without any further action required to effect such disposition),
in favour of a person  designated in writing by the holders of a majority of the
Exchangeable  Shares then  outstanding,  effective as at the date of my death or
the date on which my incapacity has been determined as mentioned above, provided
such  person  agrees to be bound to the terms  hereof  and of the  Agreement  to
Purchase  Common  Stock.  For  greater  certainty,  it is  understood  that  the
obligation  to  transfer  the  Special  Shares to the  person so named  shall be
binding upon my heirs,  successors and legal representatives who are directed on
my behalf to take all such steps as may be necessary to effect such transfer.

Although I understand  that it is not the intention of VisualMed U.S. to declare
dividends or otherwise distribute proceeds to its shareholders, I hereby confirm
that in such event,  any  proceeds I receive as a holder of the  Special  Shares
will be held in trust by me for the  benefit of and made over to the  holders of
Exchangeable Shares then outstanding on a pro rata basis.

VisualMed  Canada agrees to indemnify and hold harmless the undersigned from and
against any actions,  claims in damages,  lawsuits or other  proceedings  of any
nature and to indemnify me against any losses  arising  therefrom in  connection
with the  exercise by me of my voting  rights in the Special  Shares as provided
for herein.

If you are in agreement  with the  foregoing,  please sign in the space provided
below.

Yours very truly,






Richard Le Hir

Agreed to and accepted this 9th day of May, 2000.

VisualMed Clinical Systems Inc.

Per:







Arthur Gelston
President


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission